NeuBase Therapeutics, Inc. Derivative Liability, Current
NeuBase Therapeutics, Inc. had Derivative Liability, Current of $3.43 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2023-11-09
- 2023-09-30: Derivative Liability, Current $3.43M.
- 2023-06-30: Derivative Liability, Current $4.24M.
- 2022-12-31: Derivative Liability, Current $0.00.
- 2012-12-31: Derivative Liability, Current $2.17M.
| Period end | Derivative Liability, Current |
|---|---|
| 2023-09-30 | $3.43M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $4.24M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-09 |
| 2012-12-31 | $2.17M 10-Q · filed 2013-02-19 |
| 2012-09-30 | $768.70K 10-K · filed 2013-12-27 |
| 2012-06-30 | $2.08M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $2.26M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $5.21M 10-Q/A · filed 2012-02-14 |
| 2011-09-30 | $5.89M 10-K · filed 2013-01-09 |
| 2010-09-30 | $1.39M 10-K/A · filed 2012-01-18 |